Review
Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet]
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug.
- PMID: 30299644
- Bookshelf ID: NBK531617
Item in Clipboard
Review
Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet]
Excerpt
The objective of this overview is to systematically review and summarize the evidence of the benefits and harms associated with extended DAPT following PCI with stenting.
Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.
Sections
- Reviewers
- Authorship
- Contributors
- Conflicts of Interest
- Abbreviations
- Executive Summary
- Context and Policy Issues
- Research Questions
- Methods
- Results
- Discussion
- Conclusions
- References
- Appendix 1. Literature Search Strategy
- Appendix 2. Selection of Included Studies
- Appendix 3. List of Included Studies
- Appendix 4. List of Excluded Studies
- Appendix 5. AMSTAR Rating for Included Systematic Reviews
- Appendix 6. Definitions Used in Randomized Controlled Trials
- Appendix 7. Rapid Reviews
Similar articles
-
Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review.BMJ Open. 2019 Jun 16;9(6):e022271. doi: 10.1136/bmjopen-2018-022271. BMJ Open. 2019. PMID: 31209080 Free PMC article.
-
Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review.BMJ Open. 2017 Apr 4;7(4):e015421. doi: 10.1136/bmjopen-2016-015421. BMJ Open. 2017. PMID: 28377396 Free PMC article.
-
Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration — Project Protocol [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb. PMID: 30260612 Free Books & Documents. Review.
-
Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis.CMAJ Open. 2023 Feb 7;11(1):E118-E130. doi: 10.9778/cmajo.20210119. Print 2023 Jan-Feb. CMAJ Open. 2023. PMID: 36750248 Free PMC article.
-
Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. PMID: 31246386 Free Books & Documents. Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
